ロード中...

Stereotactic Injection of DTI-015 into Recurrent Malignant Gliomas: Phase I/II Trial

DTI-015 (BCNU in 100% ethanol) utilizes solvent facilitated perfusion for the intratumoral treatment of gliomas. The ethanol solvent vehicle facilitates a rapid and thorough saturation of the tumor with the dissolved anticancer agent BCNU. We conducted a phase I/II dose escalation study of DTI-015 i...

詳細記述

保存先:
書誌詳細
主要な著者: Hassenbusch, Samuel J, Nardone, Emilio M, Levin, Victor A, Leeds, Norman, Pietronigro, Dennis
フォーマット: Artigo
言語:Inglês
出版事項: Neoplasia Press Inc. 2003
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1502123/
https://ncbi.nlm.nih.gov/pubmed/12659665
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!